by David A. Steenblock (Author), Anthony G. Payne (Author)
The debate over the use of Embryonic stem cells and the questionable effectiveness of adult stem cells have led many scientists and clinicians to concentrate their energies on umbilical-cord-derived stem cells from healthy newborn babies. Amassing a very respectable track record in terms of safety and clinical utility, cord-blood stem cells can treat many diseases such as multiple sclerosis, amyotrophic lateral sclerosis, stroke, diabetes, heart disease and certain degenerative eye disorders.
Author Biography
A pioneering research-oriented physician and director of Steenblock Research Institute. Dr. Steenblock's Therapeutics Medical Clinic offers a comprehensive neuro-rehab program for stroke and leading-edge care for a wide variety of chronic diseases and conditions.